Pricing Log in Create free account
Friday 6 November 2026 Export UFPT’s income statement to Excel — free account

UFP Technologies, Inc.

UFPT Healthcare Medical Devices

UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.

Revenue
+11.6%
EPS
+25.6%
Free cash flow
−35.8%
Total debt
−40.2%

Quarter to September 2026, against a year earlier

302.33 2.51 +0.84%
Market cap
$2.3B
P/E
30.1×
Fwd P/E
29.2×
Dividend yield
—
F-score
5/9
Altman Z
6.86
Beneish M
−2.57
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

UFP Technologies, Inc. (UFPT) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, UFP Technologies, Inc. (UFPT) trades at a EV/EBITDA of 20.5×. Over the past ten years it has ranged from 6.9× (July 2015) to 37.9× (September 2024); the current reading is higher than 87% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 16.5× (23.52%)
FY2024 21.6× 15.44%
FY2023 18.7× 36.01%
FY2022 13.7× (32.09%)
FY2021 20.2× 55.31%
FY2020 13.0× 16.54%
FY2019 11.2× 26.48%
FY2018 8.8× (5.37%)
FY2017 9.3× 7.90%
FY2016 8.7× 1.51%

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 20.5× 9.19%
Jun 2026 18.7× 29.12%
Mar 2026 14.5× (12.03%)
Dec 2025 16.5× 9.89%
43 more quarters

Against its own ten years

Low 6.9× High 37.9×
Ten-year median 13.9×
Current reading's percentile 87

EV/EBITDA against peers

Company EV/EBITDA
BFLY Butterfly Network, Inc. compare n/m
ESTA Establishment Labs Holdings Inc. compare n/m
NVCR NovoCure Limited compare n/m
AXGN AxoGen, Inc. compare n/m
ALMR Alamar Biosciences, Inc. compare n/m
UFPT UFP Technologies, Inc. 20.5×
TMDX TransMedics Group, Inc. compare 22.0×
NEOG Neogen Corporation compare 27.2×
INSP Inspire Medical Systems, Inc. compare 48.4×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on UFPT